Robert L. Nussbaum, is the Chief Medical Officer of Invitae, a genetic information and diagnostic company. He is board certified in internal medicine, clinical genetics and clinical molecular genetics, and is a Fellow of the American College of Physicians and the American College of Medical Genetics and Genomics. From 2006-2015, he was the Holly Smith Professor of Medicine at UCSF, Chief of the Division of Genomic Medicine and Medical Director of both the Cancer Risk Program and the UCSF Program in Cardiovascular Genetics.

He trained in Medicine at Harvard Medical School, internal Medicine at Washington University/Barnes Hospital in St. Louis, and received Clinical Genetics training at Baylor College of Medicine.

He is the co-author of over 250 peer-reviewed publications in basic  human genetics and clinical medical genetics as well as numerous commentaries, editorials, and textbook chapters. He was elected to the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine and the American Academy of Arts and Sciences. Dr. Nussbaum served as a member of the Board of Directors and President of the American Society of Human Genetics, on the Board of Directors of the American Board of Medical Genetics and Genomics, was a founding fellow and member of the Board of Directors of the American College of Medical Genetics and Genomics, and was elected a fellow of the American College of Physicians.  He is the recipient of many awards for research and teaching including the Klaus Joachim Zülch-Prize for Neurological Research from the Gertrud Reemtsma Foundation/Max Planck Society (2011), the Van Andel Prize for Achievement in Parkinson Disease Research (2015), an Education Award from the American Society of Human Genetics (Co-awardee with Drs. Huntington Willard and Roderick McInnes) (2015) and the Donald Calne honorary lectureship, Parkinson Canada (2016).